Upstate Active Clinical Trials

Study Title:

S1802 - Phase III Randomized Trial of Standard Systemic Therapy (SST) versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer

What is the purpose of the study? (in Layman's terms, please describe the study)

Can we lower the chance of your prostate cancer growing or spreading by adding either prostate removal surgery or radiation therapy to the usual combination of drugs?

Upstate Institutional Review Board (IRB) Number:

1379979

Study/Protocol ID:

S1802

Study Phase:

3

Patient Age Group:

Adults

Principal Investigator:

Gennady Bratslavsky, MD

What is involved if I participate?

• How long is the study?
  Contact CRA for additional information about timeline of trial.
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  Physical exam, bloodwork, definitive radiation or prostatectomy

Where will the study take place?

Upstate Cancer Center
Upstate Specialty Services at Harrison Center
Upstate Radiation Oncology at Oneida, Oswego, and the Hill

Other Information:

Contact CRA for additional information

ClinicalTrials.Gov ID:

NCT03678025

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Nicholas Carusone, BS
Phone: 315-464-5296
Email: [email protected]

Return to Previous Page || Search Again